Join to View Full Profile
750 E Adams StRegional Oncology CenterSyracuse, NY 13210
Phone+1 315-464-8200
Fax+1 315-464-8206
Dr. Gentile is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1993 - 1996- SUNY Upstate Medical UniversityResidency, Internal Medicine, 1989 - 1993
SUNY Upstate Medical UniversityClass of 1989
Certifications & Licensure
NY State Medical License 1991 - 2027
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
- Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
- Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsUtilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States.Prashanth Ashok Kumar, Krishna Ghimire, Elio Haroun, Joseph Kassab, Ludovic Saba
European Journal of Haematology. 2024-03-01 - Descriptive Analysis and Factors Influencing Survival in Patients With Primary Cutaneous Gamma-Delta T Cell Lymphoma. A Retrospective National Cancer Database Study.Prashanth Ashok Kumar, Abirami Sivapiragasam, Dongliang Wang, Danning Huang, Teresa Gentile
Clinical Lymphoma, Myeloma & Leukemia. 2023-12-01 - Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm.Prashanth Ashok Kumar, Mulham Ombada, Gayatri Pemmasani, Ajay Tambe, Katalin Banki
Journal of Investigative Medicine High Impact Case Reports. 2022-11-07
Press Mentions
Resident ReportJune 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
